scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1012605267 |
P356 | DOI | 10.1023/B:NERE.0000029569.20266.3F |
P698 | PubMed publication ID | 15260134 |
P2093 | author name string | M D'Amico | |
M Martire | |||
C Cannizzaro | |||
P Preziosi | |||
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures | Q48963650 | ||
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. | Q52023779 | ||
Studies on the release of exogenous and endogenous GABA and glutamate from rat brain synaptosomes | Q72495598 | ||
K(+)-Evoked [(3)H]D-aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists | Q73264984 | ||
The capsaicin receptor: a heat-activated ion channel in the pain pathway | Q24322558 | ||
The effects of cannabinoids on the brain | Q28137626 | ||
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 | ||
Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
A second endogenous cannabinoid that modulates long-term potentiation | Q28248073 | ||
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice | Q28343324 | ||
Capsaicin inhibits phospholipase C-mediated Ca(2+) increase by blocking thapsigargin-sensitive store-operated Ca(2+) entry in PC12 cells | Q28372974 | ||
Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1) | Q28376536 | ||
Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 | ||
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain | Q31570267 | ||
Presence and functional regulation of cannabinoid receptors in immune cells | Q33720122 | ||
Pharmacology of cannabinoid receptor ligands. | Q33724151 | ||
Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. | Q33895436 | ||
Endocannabinoid signaling in the brain | Q34125520 | ||
Cannabis and the brain | Q34199483 | ||
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system | Q34745063 | ||
Functions of cannabinoid receptors in the hippocampus | Q34750566 | ||
Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. | Q35035824 | ||
Pharmacology of cannabinoid receptors | Q40437020 | ||
Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. | Q41683694 | ||
Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons | Q41689849 | ||
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. | Q43641975 | ||
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. | Q43742950 | ||
Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes | Q44462652 | ||
Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. | Q44497328 | ||
The GTP-binding protein, Go, regulates neuronal calcium channels | Q44508440 | ||
Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action | Q44658276 | ||
A simple apparatus for studying the release of neurotransmitters from synaptosomes | Q45134620 | ||
Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms | Q47250105 | ||
Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation | Q48120764 | ||
A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain | Q48150235 | ||
Aminoalkylindoles: actions on specific G-protein-linked receptors | Q48752690 | ||
P433 | issue | 8 | |
P921 | main subject | anandamide | Q410228 |
cannabinoids | Q422936 | ||
P304 | page(s) | 1553-1561 | |
P577 | publication date | 2004-08-01 | |
P1433 | published in | Neurochemical Research | Q15716728 |
P1476 | title | Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus | |
P478 | volume | 29 |
Q33919968 | ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells |
Q39148600 | Acetaldehyde, Motivation and Stress: Behavioral Evidence of an Addictive ménage à trois |
Q33621756 | Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex. |
Q39455101 | Inhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids |
Q33814030 | Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus |
Q28295045 | Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory |
Q36358712 | Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate |
Q37651666 | The Ratio of 2-AG to Its Isomer 1-AG as an Intrinsic Fine Tuning Mechanism of CB1 Receptor Activation |
Q37142233 | The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. |
Search more.